{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Cardiotoxins", "Dilated Cardiomyopathy", "Doxorubicin", "Oxidative Stress", "Ozone"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "25097769", "DateCompleted": {"Year": "2014", "Month": "08", "Day": "06"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2014", "Month": "07", "Day": "24"}], "ELocationID": [], "Journal": {"ISSN": "2075-051X", "JournalIssue": {"Volume": "14", "Issue": "3", "PubDate": {"Year": "2014", "Month": "Aug"}}, "Title": "Sultan Qaboos University medical journal", "ISOAbbreviation": "Sultan Qaboos Univ Med J"}, "ArticleTitle": "Ozone-Oxidative Preconditioning Prevents Doxorubicin-induced Cardiotoxicity in Sprague-Dawley Rats.", "Pagination": {"StartPage": "e342", "EndPage": "e348", "MedlinePgn": "e342-8"}, "Abstract": {"AbstractText": ["Induced dilated cardiomyopathy is the main limitation of the anti-cancer drug doxorubicin, which causes oxidative stress and cardiomyocyte death. As ozone therapy can activate the antioxidant systems, this study aimed to investigate the therapeutic efficacy of ozone-oxidative preconditioning against doxorubicin-induced cardiotoxicity.", "The study was carried out from September 2013 to January 2014. Sprague-Dawley rats were randomly distributed in the following treatment groups: Group 1 were treated with 2 mg/kg intraperitoneal (i.p.) of doxorubicin twice a week for 50 days; Group 2 were treated with 0.3 mg of ozone/oxygen mixture at 50 \u03bcg/mL of ozone per 6 mL of oxygen by rectal insufflation and then treated with doxorubicin; Group 3 were treated as Group 2 but only with the oxygen, and Group 4 were treated with oxygen first, and then with sodium chloride i.p. as the control group.", "The results showed that ozone therapy preserved left ventricle morphology which was accompanied by a reduction of serum pro-brain natriuretic peptide levels. The cardioprotective effects of ozone-oxidative preconditioning were associated with a significant increase (P <0.05) of antioxidant enzymes activities and a reduction of lipid and protein oxidation (P <0.05).", "Ozone-oxidative preconditioning prevents doxorubicin-induced dilated cardiomyopathy through an increase of antioxidant enzymes and a reduction of oxidised macromolecules. This establishes the background for future studies to determine if ozone therapy can be used as a complementary treatment for attenuating doxorubicin-induced cardiotoxicity in cancer patients."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Studies for Research & Biological Evaluations, Pharmacy & Food Science College, University of Havana, Cuba;"}], "LastName": "Delgado-Roche", "ForeName": "Livan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Studies for Research & Biological Evaluations, Pharmacy & Food Science College, University of Havana, Cuba;"}], "LastName": "Hern\u00e1ndez-Matos", "ForeName": "Yanet", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Studies for Research & Biological Evaluations, Pharmacy & Food Science College, University of Havana, Cuba;"}], "LastName": "Medina", "ForeName": "Emilio A", "Initials": "EA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Studies for Research & Biological Evaluations, Pharmacy & Food Science College, University of Havana, Cuba;"}], "LastName": "Morej\u00f3n", "ForeName": "Dalia \u00c1", "Initials": "D\u00c1"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "LABIOFAM Pharmaceutical Laboratories, Havana, Cuba;"}], "LastName": "Gonz\u00e1lez", "ForeName": "Mait\u00e9 R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Center Beauty Benefit, Osimo, Ancona, Italy."}], "LastName": "Mart\u00ednez-S\u00e1nchez", "ForeName": "Gregorio", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Oman", "MedlineTA": "Sultan Qaboos Univ Med J", "NlmUniqueID": "101519915", "ISSNLinking": "2075-051X"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Blum RH, Carter SK. Adriamycin: A new anti-cancer drug with significant clinical activity. Ann Intern Med. 1974;80:249\u201359. doi: 10.7326/0003-4819-80-2-249.", "ArticleIdList": ["10.7326/0003-4819-80-2-249", "4590654"]}, {"Citation": "Mukherjee S, Banerjee SK, Maulik M, Dinda AK, Talwar KK, Maulik SK. Protection against acute adriamycin-induced cardiotoxicity by garlic: Role of endogenous antioxidants and inhibition of TNF-alpha expression. BMC Pharmacol. 2003;3:16. doi: 10.1186/1471-2210-3-16.", "ArticleIdList": ["10.1186/1471-2210-3-16", "PMC324401", "14687418"]}, {"Citation": "Konorev EA, Vanamala S, Kalyanaraman B. Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Free Radic Biol Med. 2008;45:1723\u20138. doi: 10.1016/j.freeradbiomed.2008.09.006.", "ArticleIdList": ["10.1016/j.freeradbiomed.2008.09.006", "PMC3039518", "18926904"]}, {"Citation": "Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808\u201315. doi: 10.1056/NEJM199103213241205.", "ArticleIdList": ["10.1056/NEJM199103213241205", "1997853"]}, {"Citation": "Schwarz ER, Pollick C, Dow J, Patterson M, Birnbaum Y, Kloner RA. A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography. Cardiovasc Res. 1998;39:216\u201323. doi: 10.1016/S0008-6363(98)00009-1.", "ArticleIdList": ["10.1016/S0008-6363(98)00009-1", "9764201"]}, {"Citation": "Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: Part I. Br J Haematol. 2002;118:3\u201322. doi: 10.1046/j.1365-2141.2002.03470.x.", "ArticleIdList": ["10.1046/j.1365-2141.2002.03470.x", "12100125"]}, {"Citation": "Kim DS, Woo ER, Chae SW, Ha KC, Lee GH, Hong ST, et al. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation. Life Sci. 2007;80:314\u201323. doi: 10.1016/j.lfs.2006.09.019.", "ArticleIdList": ["10.1016/j.lfs.2006.09.019", "17034819"]}, {"Citation": "Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest. 1996;98:1253\u201360. doi: 10.1172/JCI118909.", "ArticleIdList": ["10.1172/JCI118909", "PMC507548", "8787689"]}, {"Citation": "Lebrecht D, Setzer B, Ketelsen UP, Haberstroh J, Walker UA. Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation. 2003;108:2423\u20139. doi: 10.1161/01.CIR.0000093196.59829.DF.", "ArticleIdList": ["10.1161/01.CIR.0000093196.59829.DF", "14568902"]}, {"Citation": "Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997;47:287\u201396. doi: 10.1046/j.1365-2265.1997.2361058.x.", "ArticleIdList": ["10.1046/j.1365-2265.1997.2361058.x", "9373449"]}, {"Citation": "Ajamieh H, Merino N, Candelario-Jalil E, Men\u00e9ndez S, Martinez-Sanchez G, Re L, et al. Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury. Pharmacol Res. 2002;45:333\u20139. doi: 10.1006/phrs.2002.0952.", "ArticleIdList": ["10.1006/phrs.2002.0952", "12030798"]}, {"Citation": "Mart\u00ed nez-S\u00e1nchez G, Al-Dalain SM, Men\u00e9ndez S, Re L, Giuliani A, Candelario-Jalil E, et al. Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005;523:151\u201361. doi: 10.1016/j.ejphar.2005.08.020.", "ArticleIdList": ["10.1016/j.ejphar.2005.08.020", "16198334"]}, {"Citation": "Re L, Mart\u00ednez-S\u00e1nchez G, Malcangi G, Mercanti A, Labate V. Ozone therapy: A clinical study on the pain management. Int J Ozone Therap. 2008;7:37\u201344."}, {"Citation": "Delgado-Roche L, Mart\u00ednez-S\u00e1nchez G, D\u00edaz-Batista A, Re L. Effects of ozone therapy on oxidative stress biomarkers in coronary artery disease patients. Int J Ozone Therap. 2011;10:99\u2013104."}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Delgado-Roche L, D\u00edaz-Batista A, P\u00e9rez-Davison G, Re L. Effects of ozone therapy on haemostatic and oxidative stress index in coronary artery disease. Eur J Pharmacol. 2012;691:156\u201362. doi: 10.1016/j.ejphar.2012.07.010.", "ArticleIdList": ["10.1016/j.ejphar.2012.07.010", "22796450"]}, {"Citation": "Bocci VA. Scientific and medical aspects of ozone therapy: State of the art. Arch Med Res. 2006;37:425\u201335. doi: 10.1016/j.arcmed.2005.08.006.", "ArticleIdList": ["10.1016/j.arcmed.2005.08.006", "16624639"]}, {"Citation": "Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med. 2011;9:66. doi: 10.1186/1479-5876-9-66.", "ArticleIdList": ["10.1186/1479-5876-9-66", "PMC3125221", "21575276"]}, {"Citation": "Delgado-Roche L, Mart\u00ednez-S\u00e1nchez G, Re L. Ozone oxidative preconditioning prevents atherosclerosis development in New Zealand white rabbits. J Cardiovasc Pharmacol. 2013;61:160\u20135. doi: 10.1097/FJC.0b013e31827a820d.", "ArticleIdList": ["10.1097/FJC.0b013e31827a820d", "23222311"]}, {"Citation": "Delgado Roche L, Acosta Medina E, Fraga P\u00e9rez A, B\u00e9cquer Viart MA, Soto L\u00f3pez Y, Falc\u00f3n Cama V, et al. Lipofundin-induced hyperlipidemia promotes oxidative stress and atherosclerotic lesions in New Zealand white rabbits. Int J Vasc Med. 2012;2012:898769. doi: 10.1155/2012/898769.", "ArticleIdList": ["10.1155/2012/898769", "PMC3184413", "21977325"]}, {"Citation": "Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354. doi: 10.1016/0003-2697(76)90527-3.", "ArticleIdList": ["10.1016/0003-2697(76)90527-3", "942051"]}, {"Citation": "Haining JL, Legan JS. Improved assay for catalase based upon steady-state substrate concentration. Anal Biochem. 1972;45:469\u201379. doi: 10.1016/0003-2697(72)90209-6.", "ArticleIdList": ["10.1016/0003-2697(72)90209-6", "5060603"]}, {"Citation": "Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeill\u00e8re-Blandin C, Nguyen AT, Canteloup S, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161:2524\u201332.", "ArticleIdList": ["9725252"]}, {"Citation": "Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407\u201321. doi: 10.1016/0076-6879(90)86134-H.", "ArticleIdList": ["10.1016/0076-6879(90)86134-H", "2233308"]}, {"Citation": "Ibrahim SS, Barakat MA, Helmy HM. Role of selenium in attenuating cardiac and hepatic damages induced by the antitumor agent, doxorubicin. Life Sci J. 2011;8:1\u201312."}, {"Citation": "Witko-Sarsat V, Nguyen Khoa T, Jungers P, Dr\u00fceke T, Descamps-Latscha B. Advanced oxidation protein products: Oxidative stress markers and mediators of inflammation in uremia. Adv Nephrol Necker Hosp. 1998;28:321\u201341.", "ArticleIdList": ["9889997"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Giuliani A, P\u00e9rez-Davison G, Le\u00f3n-Fernandez OS. Oxidized proteins and their contribution to redox homeostasis. Redox Rep. 2005;10:175\u201385. doi: 10.1179/135100005X57382.", "ArticleIdList": ["10.1179/135100005X57382", "16259785"]}, {"Citation": "Nitobe J, Yamaguchi S, Okuyama M, Nozaki N, Sata M, Miyamoto T, et al. Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc Res. 2003;57:119\u201328. doi: 10.1016/S0008-6363(02)00646-6.", "ArticleIdList": ["10.1016/S0008-6363(02)00646-6", "12504821"]}, {"Citation": "Doroshow JH, Locker GY, Myers CE. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. J Clin Invest. 1980;65:128\u201335. doi: 10.1172/JCI109642.", "ArticleIdList": ["10.1172/JCI109642", "PMC371347", "7350193"]}, {"Citation": "Harman D. The aging process: Major risk factor for disease and death. Proc Natl Acad Sci U S A. 1991;88:5360\u20133. doi: 10.1073/pnas.88.12.5360.", "ArticleIdList": ["10.1073/pnas.88.12.5360", "PMC51872", "2052612"]}, {"Citation": "Horan PG, McMullin MF, McKeown PP. Anthracycline cardiotoxicity. Eur Heart J. 2006;27:1137\u20138. doi: 10.1093/eurheartj/ehi702.", "ArticleIdList": ["10.1093/eurheartj/ehi702", "16611672"]}, {"Citation": "Kotamraju S, Chitambar CR, Kalivendi SV, Joseph J, Kalyanaraman B. Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: Role of oxidant-induced iron signaling in apoptosis. J Biol Chem. 2002;277:17179\u201387. doi: 10.1074/jbc.M111604200.", "ArticleIdList": ["10.1074/jbc.M111604200", "11856741"]}, {"Citation": "Myers C, Bonow R, Palmeri S, Jenkins J, Corden B, Locker G, et al. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol. 1983;10:53\u20135.", "ArticleIdList": ["6340204"]}, {"Citation": "Nagata Y, Takata J, Karube Y, Matsushima Y. Effects of a water-soluble prodrug of vitamin E on doxorubicin-induced toxicity in mice. Biol Pharm Bull. 1999;22:698\u2013702. doi: 10.1248/bpb.22.698.", "ArticleIdList": ["10.1248/bpb.22.698", "10443465"]}, {"Citation": "Seifert CF, Nesser ME, Thompson DF. Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity. Ann Pharmacother. 1994;28:1063\u201372. doi: 10.1177/106002809402800912.", "ArticleIdList": ["10.1177/106002809402800912", "7803884"]}, {"Citation": "Re L, Mawsouf MN, Men\u00e9ndez S, Le\u00f3n OS, S\u00e1nchez GM, Hern\u00e1ndez F. Ozone therapy: Clinical and basic evidence of its therapeutic potential. Arch Med Res. 2008;39:17\u201326. doi: 10.1016/j.arcmed.2007.07.005.", "ArticleIdList": ["10.1016/j.arcmed.2007.07.005", "18067991"]}, {"Citation": "Steppan J, Meaders T, Muto M, Murphy KJ. A metaanalysis of the effectiveness and safety of ozone treatments for herniated lumbar discs. J Vasc Interv Radiol. 2010;21:534\u201348. doi: 10.1016/j.jvir.2009.12.393.", "ArticleIdList": ["10.1016/j.jvir.2009.12.393", "20188591"]}, {"Citation": "D\u00edaz-Llera S, Gonz\u00e1lez-Hern\u00e1ndez Y, Gonz\u00e1lez Mesa JE, Mart\u00ednez-S\u00e1nchez G, Re L. Induction of DNA primary damage in peripheral blood leukocytes and exfoliated colorectal epithelial cells in rats treated with ozone. Int J Ozone Therap. 2009;8:217\u201321."}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Re L. Rectal administration and its application in ozonetherapy. Int J Ozone Therap. 2012;11:41\u20139."}, {"Citation": "Pecorelli A, Bocci V, Acquaviva A, Belmonte G, Gardi C, Virgili F, et al. NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells. Toxicol Appl Pharmacol. 2013;267:30\u201340. doi: 10.1016/j.taap.2012.12.001.", "ArticleIdList": ["10.1016/j.taap.2012.12.001", "23253326"]}, {"Citation": "Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol. 2003;43:233\u201360. doi: 10.1196/annals.1323.001.", "ArticleIdList": ["10.1196/annals.1323.001", "12359864"]}, {"Citation": "Gao AM, Ke ZP, Wang JN, Yang JY, Chen SY, Chen H. Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway. Carcinogenesis. 2013;34:1806\u201314. doi: 10.1093/carcin/bgt108.", "ArticleIdList": ["10.1093/carcin/bgt108", "23563091"]}], "ReferenceList": []}], "History": [{"Year": "2013", "Month": "9", "Day": "28"}, {"Year": "2014", "Month": "3", "Day": "8"}, {"Year": "2014", "Month": "3", "Day": "20"}, {"Year": "2014", "Month": "8", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "8", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "8", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2014", "Month": "8", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["25097769", "PMC4117659"]}}], "PubmedBookArticle": []}